This compound is a pharmaceutical intermediate featuring a triazolopyrazine core with a thiadiazole substituent and a tert-butyl ester protecting group. It is primarily supplied for use in research and manufacturing processes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1629229-88-4
4-(Piperidin-4-yl)benzonitrile--hydrogen chloride (1/1)
pharmaceutical intermediate
Bis((2R,4R,5R,7R)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
pharmaceutical intermediate
(3S,4R)-4-aminooxan-3-ol hydrochloride
pharmaceutical intermediate
(3R,4S)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride
Pharmaceutical intermediate
Fezolinetant Impurity 3
Pharmaceutical intermediate
tert-butyl (8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine-7-carboxylate
YPGPEKQJPUMUNS-MRVPVSSYSA-N
C[C@@H]1C2=NN=C(N2CCN1C(=O)OC(C)(C)C)C3=NC(=NS3)C
—